Qromed Remedies Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 08-07-2024
- Paid Up Capital ₹ 0.10 M
as on 08-07-2024
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.00 M
as on 08-07-2024
- Satisfied Charges ₹ 6.00 M
as on 08-07-2024
- Revenue 93.25%
(FY 2022)
- Profit 274.00%
(FY 2022)
- Ebitda 163.25%
(FY 2022)
- Net Worth 243.25%
(FY 2022)
- Total Assets 14.25%
(FY 2022)
About Qromed Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹6.00 M. The company has closed loans amounting to ₹6.00 M, as per Ministry of Corporate Affairs (MCA) records.
Balakrishna Sakhare, Vishwanath Shindholimath, Ramakrishna, and Sixteen other members serve as directors at the Company.
- CIN/LLPIN
U24290KA2018PTC110128
- Company No.
110128
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Feb 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Qromed Remedies?
Board Members(19)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinod Ratageri  | Director | 13-Feb-2018 | Current |
| Chidanand Mudkavi | Director | 13-Feb-2018 | Current |
| Balakrishna Sakhare | Director | 13-Feb-2018 | Current |
| Vishwanath Shindholimath | Director | 13-Feb-2018 | Current |
| Ramakrishna | Director | 13-Feb-2018 | Current |
| Ravikumar Malladad | Director | 15-Nov-2021 | Current |
Financial Performance of Qromed Remedies.
Qromed Remedies Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 93.25% increase. The company also saw a substantial improvement in profitability, with a 274% increase in profit. The company's net worth Soared by an impressive increase of 243.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Qromed Remedies?
In 2021, Qromed Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shri Balaji Sugars And Chemicals Private LimitedActive 13 years 8 monthsAjit Kanakaraddi is a mutual person
- Nuzen Innovations LlpActive 2 years 7 days
Basanagouda Karegoudar and Saroja Karegoudar are mutual person
- Tatwadarsha Healthcare Solutions Private LimitedActive 14 years 4 months
Sunil Gayad is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Dec 2022 | ₹6.00 M | Open |
Bank Of India Creation Date: 01 Mar 2019 | ₹6.00 M | Satisfied |
How Many Employees Work at Qromed Remedies?
Qromed Remedies has a workforce of 8 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Qromed Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Qromed Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
